AMGN Icon

$AMGN

$AMGN

Amgen

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The companys principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçets disease; Prolia to treat postmenopausal women with ...

Stocks

Total Asset Value

$9,021

+149.29%from 30d ago

Net Asset Value

$442

+17.60%from 30d ago

Holders

62

+40.91%from 30d ago

Monthly Transfer Volume

$10.81K

75.26%from 30d ago

Amgen Metrics

Tokenized Public Stocks

10 Total